Department of Thoracic Surgery, University of Health Sciences, Ankara City Hospital, Bilkent, Ankara, Turkey.
Department of Infectious Diseases, Istanbul Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Istanbul, Turkey.
Ir J Med Sci. 2022 Jun;191(3):1075-1079. doi: 10.1007/s11845-021-02722-z. Epub 2021 Jul 31.
SARS-CoV-2 coronavirus disease 19 (COVID-19), which was detected in December 2019, whose first cases were observed in Turkey on 11 March 2020, and which was declared a pandemic by the World Health Organization on the same day, has become a public health problem worldwide and has required the adaptation of medical practices to the current situation. In the current paper, we present our experience and practices regarding thoracic surgery from the largest pandemic hospital in Europe over the 1-year period of the pandemic.
Patients who were operated by our thoracic surgery clinic in the largest pandemic hospital in Europe between March 2020 and March 2021 in the COVID-19 pandemic in our country and in the world were evaluated retrospectively.
Eighty-five patients were operated on during the 1-year pandemic, of which 54 (63.5%) were men and 31 (36.5%) were women. The mean patient age was 47.7. Morbidity rate was 12%. The average number of PCR tests performed in the preoperative period for COVID-19 disease was 1.6. Sixteen patients had a history of COVID-19 before surgery. COVID-19 was not seen in any patient in our clinic during the postoperative period. Only one patient died out of those who underwent surgery. That patient died due to multiorgan failure.
Thoracic surgery has one of the highest risks due to direct contact with the lungs, especially in terms of surgery and the postoperative period. We consider that this risk will be minimized by taking measures during all processes. Moreover, we think that surgical treatments should be delayed as little as possible due to the special status of oncology patients. In addition, considering that if all these rules are followed in the COVID-19 pandemic and in other types of pandemics that may occur in the future, there will be no delay or insufficiency in the treatment of patients and healthcare professionals will be able to work safely.
SARS-CoV-2 冠状病毒病 19（COVID-19）于 2019 年 12 月被发现，其首例病例于 2020 年 3 月 11 日在土耳其观察到，同日世界卫生组织宣布其为大流行，已成为全球公共卫生问题，并要求医疗实践适应当前形势。在本文中，我们介绍了在欧洲最大的大流行医院进行胸外科手术的经验和做法，时间跨度为大流行的 1 年。
回顾性分析了 2020 年 3 月至 2021 年 3 月在我国和世界大流行期间在欧洲最大的大流行医院进行胸外科手术的患者。
在大流行的 1 年内，共有 85 例患者接受了手术，其中 54 例（63.5%）为男性，31 例（36.5%）为女性。患者平均年龄为 47.7 岁。发病率为 12%。在术前阶段，平均进行了 1.6 次针对 COVID-19 疾病的 PCR 检测。16 例患者术前有 COVID-19 病史。在我们的诊所中，术后没有任何患者出现 COVID-19。接受手术的患者中只有 1 例死亡。该患者死于多器官衰竭。
由于直接接触肺部，胸外科手术的风险最高，尤其是在手术和术后期间。我们认为，通过在所有过程中采取措施，可以将这种风险降至最低。此外，由于肿瘤患者的特殊情况，我们认为应尽可能延迟手术治疗。此外，考虑到如果在 COVID-19 大流行和未来可能发生的其他类型大流行中遵循所有这些规则，就不会延误患者的治疗，医疗保健专业人员将能够安全地工作。
